Resilient Pharmaceuticals

Resilient Pharmaceuticals, formerly known as Lykos Therapeutics and before that as the MAPS Public Benefit Corporation (MAPS PBC), is a public benefit corporation (PBC) developing MDMA ("ecstasy") for potential medicinal use. It was founded and is part-owned by the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS).